Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
2 hedge funds and large institutions have $1.21K invested in Altamira Therapeutics Ltd in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
60% less funds holding
Funds holding: 5 → 2 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
98% less capital invested
Capital invested by funds: $71.3K → $1.21K (-$70.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$5.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$61.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.35K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$9 |
| 4 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XT
1
XTX Topco
George Town,
Cayman Islands
| $1.21K | +$5.5K | +10,926 | New |
|
|
AC
2
Armistice Capital
New York
| – | -$61.9K | -101,444 | Closed |
|
|
3
Citadel Advisors
Miami,
Florida
| – | -$9.35K | -14,802 | Closed |
|
|
4
Group One Trading
Chicago,
Illinois
| – | -$9 | -14 | Closed |
|
|
DB
5
Danske Bank
Copenhagen K,
Denmark
| – | -$1 | -1 | Closed |
|
CYTO Hedge Fund Activity: Q4 2024 in Review
2 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q4 2024, worth a combined $1.21K — down 98% from $71.3K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CYTO and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $5.5K. The largest seller was Armistice Capital, exiting entirely with an estimated $61.9K sold.
- 2 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q4 2024, down from 5 in Q3 2024.
- Funds reported $1.21K of Altamira Therapeutics Ltd stock for Q4 2024, down 98% quarter-over-quarter.
- 1 fund opened new Altamira Therapeutics Ltd positions in Q4 2024 and 4 closed out, a net change of -3 holders.
- The largest Altamira Therapeutics Ltd buyer in Q4 2024 was XTX Topco, an estimated $5.5K added.
- The largest Altamira Therapeutics Ltd seller in Q4 2024 was Armistice Capital, an estimated $61.9K sold.
Based on aggregated 13F filings for Q4 2024.